Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00026871
What this trial is testing

Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System

Who this might be right for
Neoplasm
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT02336360
What this trial is testing

Augmenting Flortaucipir Dosimetry Estimates

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07835880
What this trial is testing

[18F]FIDT-10b PET Imaging in Cardiac Amyloidosis

Who this might be right for
Transthyretin Cardiac AmyloidosisLight Chain Cardiac Amyloidosis
Peking Union Medical College Hospital 48
Early research (Phase 1)UnknownNCT01159405
What this trial is testing

The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer

Who this might be right for
Breast Cancer
SeeCure LLC 9
Not applicableStudy completedNCT01132872
What this trial is testing

PET Whole Body Distribution Studies Using [11C]CUMI

Who this might be right for
DepressionMajor DepressionUnipolar Depression+2 more
National Institute of Mental Health (NIMH) 12
Testing effectiveness (Phase 2)UnknownNCT05299437
What this trial is testing

Metastatic Thyroid Cancer Therapy Optimization With 124I PET Dosimetry

Who this might be right for
Metastatic Differentiated Thyroid Cancer
Carlo Chiesa 50
Not applicableStudy completedNCT00245349
What this trial is testing

Study to Calculate the Radiation Dosimetry in Subjects With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Iowa 9
Early research (Phase 1)UnknownNCT03422055
What this trial is testing

Study of Tolerance, Biodistribution and Dosimetry of Fucoidan Radiolabeled by Technetium-99m

Who this might be right for
Healthy Volunteer
Assistance Publique - Hôpitaux de Paris 10
Not applicableStudy completedNCT04517643
What this trial is testing

TheraSphere® For Treatment of Metastases in Liver

Who this might be right for
Colorectal Cancer MetastaticColorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Early research (Phase 1)Study completedNCT00339131
What this trial is testing

ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid

Who this might be right for
PheochromocytomaParagangliomaCarcinoid
Molecular Insight Pharmaceuticals, Inc. 24
Early research (Phase 1)Looking for participantsNCT06531499
What this trial is testing

Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Novartis Pharmaceuticals 106
Testing effectiveness (Phase 2)Looking for participantsNCT06773663
What this trial is testing

Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism

Who this might be right for
Primary AldosteronismPrimary Aldosteronism Due to Aldosterone Producing Adenoma
Peking Union Medical College Hospital 150
Not applicableStudy completedNCT05179161
What this trial is testing

Validation of Prone Crawl Radiotherapy for Whole-breast Irradiation After Breast Conserving Surgery

Who this might be right for
Breast Cancer Female
University Hospital, Ghent 40
Not applicableStudy completedNCT04172714
What this trial is testing

Low-dose Y90 Treatment Planning for HCC

Who this might be right for
HCCCancer of LiverCancer
Emory University 30
Not applicableStudy completedNCT03890926
What this trial is testing

The Physical Dosimetry Study and Preliminary Clinical Results of 3D-printing Non Co-planar Template Assisted With CT-guidance for Iodine-125 Seed Brachytherapy in Pelvic Recurrent Rectum Carcinoma After Surgery and External Beam Radiotherapy

Who this might be right for
Rectum Cancer, RecurrentBrachytherapy, Radioisotope
Peking University Third Hospital 66
Very early researchNot Yet RecruitingNCT07609225
What this trial is testing

Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
University of Wisconsin, Madison 15
Testing effectiveness (Phase 2)Looking for participantsNCT06925581
What this trial is testing

A Trial of HRS-6768 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd. 84
Not applicableStudy completedNCT06398392
What this trial is testing

Radiation Dosimetry of the 18 kDa Translocator Protein Ligand [18F]PBR111 in Humans

Who this might be right for
DosimetryHealthy
Prof. Daniele Zullino 6
Early research (Phase 1)Study completedNCT04786847
What this trial is testing

177Lu-DOTA-TLX591 Safety, Biodistribution and Dosimetry Study

Who this might be right for
Metastatic Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Limited 30
Early research (Phase 1)Looking for participantsNCT07114601
What this trial is testing

LY4257496 in Participants With Cancer (OMNIRAY)

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsProstate Neoplasm+4 more
Eli Lilly and Company 421
Next Page